Position in RXRX
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$255,065
-$4,350 QoQ
Shares Held
69,500
-17.8% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#4
of 28 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Plancorp, LLC holds $5,642,142 across 6 Biotechnology names. RXRX ranks #5 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IBRX |
ImmunityBio, Inc.
|
396,354 | $3,470,079 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
11,128 | $882,339 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
907 | $565,550 | |
| 4 | EXEL |
Exelixis, Inc.
|
8,068 | $438,979 | |
| 5 | RXRX |
Recursion Pharmaceuticals, Inc.
This page
|
69,500 | $255,065 | |
| 6 | GNLX |
GENELUX Corp
|
10,010 | $30,130 |
All Filings in RXRX
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $255,065 | 69,500 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $259,415 | 84,500 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $345,605 | 84,500 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $436,760 | 89,500 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $452,870 | 89,500 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $474,386 | 89,676 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $592,067 | 87,584 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $511,278 | 77,584 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $529,575 | 70,610 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $275,271 | 27,610 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $104,614 | 10,610 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $81,855 | 10,700 | Shares | Sole | 2023-11-08 | |
| No filing history on record for this holder in this stock. | ||||||